Choosing The Right Psychedelic Therapy Clinic In Rockland: What Matters Most

(MENAFN- Market Press Release) September 3, 2026 1:34 am - A closer look at what patients should consider when choosing a psychedelic therapy clinic in Rockland, including clinical experience, treatment options, safety, and patient support

Interest in psychedelic-assisted therapy has grown significantly in recent years, giving people with treatment-resistant depression and other mental health conditions access to treatments that were rarely available a decade ago. Alongside that growth has come a rising number of clinics offering ketamine-based treatments - making it harder for patients to understand what truly differentiates one provider from another.

One point often gets lost in that noise: Spravato® (esketamine) is currently the only FDA-approved psychedelic medicine in the United States. Ketamine, delivered under medical supervision, is the closest legally available psychedelic-adjacent treatment. Both are available at Marpa Minds - but the treatments themselves are only part of what defines quality care.

For individuals considering psychedelic-assisted therapy in New York - especially across Rockland County, Westchester County and neighbouring Bergen County NJ - choosing the right clinic starts with understanding what defines quality care rather than comparing treatment options alone.

What Actually Defines a Reliable Psychedelic Therapy Clinic
Not every clinic follows the same clinical model. Some focus primarily on administering treatment, while others provide comprehensive psychiatric care that begins well before the first session and continues throughout a patient's progress.

A high-quality psychedelic therapy clinic should combine four elements into one coordinated approach:
1 psychiatric evaluation - Determining whether treatment is clinically appropriate through a full
2 treatment planning - Tailoring recommendations to each patient's diagnosis, history, and clinical needs rather than a one-size-fits-all
3 supervision - Delivering treatment in a REMS-certified setting under direct clinical
4 follow-up - Adjusting treatment as a patient's needs evolve over time, not just during isolated sessions.

Looking beyond a clinic's service menu to understand how care is delivered often provides a clearer picture of quality than any list of treatments could.

Questions to Ask Before Choosing a Psychedelic Therapy Clinic
Comparing clinics is easier when patients know what to ask during their initial consultation. The most important questions to raise include:
1 conducts the psychiatric evaluation and determines treatment eligibility?
2 treatment tailored to your specific diagnosis, treatment history, and clinical needs?
3 level of medical supervision is provided during treatment sessions?
4 does the clinic monitor progress and adjust treatment over time?
5 follow-up care is available after treatment begins?
6 the clinic handle insurance verification and prior authorization directly?
7 Spravato® - the only FDA-approved psychedelic medicine - offered alongside ketamine therapy, or is the clinic limited to a single treatment?

The answers reveal more about the quality of care than a website ever could. A thoughtful evaluation process and ongoing clinical involvement help ensure treatment decisions are based on each patient's circumstances rather than a standardized approach.

What Sets Marpa Minds Apart as a Psychedelic Therapy Clinic in New York
These standards form the foundation of care at Marpa Minds, an outpatient psychiatric clinic serving Rockland County, Westchester County and Bergen County NJ from locations in White Plains and Suffern, New York.

A few things set Marpa Minds apart:
Full treatment toolkit under one roof - The clinic is one of the few in the region delivering Spravato®, IV ketamine, IM ketamine, and TMS therapy under one program - allowing the clinical team to match, combine, or sequence treatments rather than fitting patients to a single option.

REMS-certified setting - Marpa Minds is a REMS-certified Spravato® provider - a federal safety standard that means treatment happens only in certified settings with structured monitoring after every dose.

Deep clinical experience - Amy Della Rocca, MSN, MPH, PMHNP-BC, Clinical Director, has personally overseen more than 5,000 Spravato® and ketamine treatment sessions, giving the clinic uncommon depth of experience with esketamine and ketamine-based care.

Insurance handled in-house - The Marpa Minds team verifies insurance benefits and manages prior authorization on the patient's behalf - reducing one of the biggest barriers to specialized depression treatment.

Board-certified psychiatric leadership - Care is led by Dr. Benjamin Medrano, MD, Practice Owner and Medical Director - a board-certified psychiatrist with extensive experience in evidence-based psychiatric care and ketamine-based treatments.

Every patient begins with a comprehensive psychiatric evaluation before any treatment recommendation is made. When clinically appropriate, care may include FDA-approved Spravato® therapy, IV or IM ketamine therapy delivered under clinical supervision, TMS, medication management, and ongoing follow-up - always based on the individual's symptoms, treatment history, and response to care.

That patient-centered approach is reflected in the experiences of individuals treated at Marpa Minds:
"After the better part of a decade, I can finally feel again. It was Spravato!!" - Rhonda T., Elementary School Teacher
"I felt like I was drowning. Marpa Minds helped me find myself again." - S.F., Real Estate Attorney

Why the Clinical Team Matters Most in Psychedelic Therapy
The effectiveness of psychedelic-assisted therapy depends not just on the treatment itself, but on the clinicians responsible for evaluating patients, making treatment decisions, and providing ongoing care.

Psychiatric expertise, familiarity with treatment-resistant depression, and hands-on experience delivering Spravato® and ketamine-based therapies all contribute to safer, more individualized treatment. Equally important is the ability to monitor progress over time, adjust treatment plans when appropriate, and support patients throughout their recovery - rather than limiting care to individual treatment sessions in isolation.

For patients comparing clinics, understanding who is leading care can matter as much as understanding the treatment itself.

Finding a Psychedelic Therapy Clinic in Rockland
Choosing a psychedelic therapy clinic involves more than picking a treatment. The quality of psychiatric evaluation, clinical experience, individualized care, and long-term support all shape the environment in which patients make informed decisions about their mental health.

About Marpa Minds
Marpa Minds is a REMS-certified outpatient psychiatric clinic providing evidence-based treatments for depression and mood disorders. With locations in White Plains, NY and Suffern, NY, Marpa Minds serves patients across Westchester County, Rockland County, and Bergen County NJ. Under the clinical leadership of Dr. Benjamin Medrano, MD, and Amy Della Rocca, MSN, MPH, PMHNP-BC, Marpa Minds offers Spravato® (esketamine) therapy, IV and IM ketamine therapy, TMS therapy, and IV nutrient therapy. The clinic handles insurance verification and prior authorization directly - helping eligible patients access advanced depression treatment without administrative barriers.

Individuals seeking more information about available depression treatment options - including eligibility, the evaluation process, or insurance coverage - can connect with the Marpa Minds team at +1 (914) 222-0101, or visit either location for personalized guidance.

Marpa Minds Locations
Westchester County:
1 Barker Ave, Suite 200, White Plains, NY 10601

Rockland County:
10 Executive Blvd., Ste 104, Suffern, NY 10901
Both locations offer Spravato® therapy, IV and IM ketamine therapy, TMS therapy, and coordinated psychiatric care for adults across Westchester, Rockland, and Bergen County NJ.

MENAFN03092026003520003262ID1111617183